
92.22 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 43.29 Today|||52-Week Range 125.61 | -17.77% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $5.6B |
Blueprint Medicines Corp. 45 Sidney Street Cambridge Massachusetts 02139 |
Jeffrey W. Albers | President, Chief Executive Officer & Director |
Kathryn Haviland | Chief Operating Officer |
Michael Landsittel | Chief Financial Officer |
Becker Hewes | Chief Medical Officer |
Fouad Namouni | President-Research & Development |